RGD peptides protects against acute lung injury in septic mice through Wisp1-integrin β6 pathway inhibition

Shock

Volumn 43, Issue 4, 2015, Pages 352-360

  Ding, Xibing ^a   Wang, Xin ^a   Zhao, Xiang ^a   Jin, Shuqing ^a   Tong, Yao ^a   Ren, Hao ^a   Chen, Zhixia ^a   Li, Quan ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Acute lung injury (ALI); Arg Gly Asp (RGDs); Cecal ligation and puncture (CLP); Integrin 6; Sepsis; Wisp1

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; BETA6 INTEGRIN; INTERLEUKIN 6; PROTEIN; PROTEIN WISP1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ARGINYL-GLYCYL-ASPARTIC ACID; BETA INTEGRIN; CCN PROTEIN; OLIGOPEPTIDE; ONCOPROTEIN; WISP1 PROTEIN, MOUSE;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; IMMUNOPRECIPITATION; LEUKOCYTE COUNT; LUNG CAPILLARY; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; SIGNAL TRANSDUCTION; SURVIVAL RATE; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BRONCHOALVEOLAR LAVAGE FLUID; C57BL MOUSE; CAPILLARY; DISEASE MODEL; IMMUNOLOGY; LUNG; METABOLISM; MICROBIOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; VASCULARIZATION;

ACUTE LUNG INJURY; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CAPILLARIES; CCN INTERCELLULAR SIGNALING PROTEINS; DISEASE MODELS, ANIMAL; IMMUNOPRECIPITATION; INTEGRIN BETA CHAINS; INTERLEUKIN-6; LUNG; MALE; MICE; MICE, INBRED C57BL; OLIGOPEPTIDES; PROTO-ONCOGENE PROTEINS; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84924907995     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000313     Document Type: Article

References (31)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303-1310, 2001.
2. Ozdulger A, Cinel I, Koksel O, Cinel L, Avlan D, Unlu A, Okcu H, Dikmengil M, Oral U: The protective effect of N-acetylcysteine on apoptotic lung injury in cecal ligation and puncture-induced sepsis model. Shock 19:366-372, 2003.
3. Das UN: Recent advances in the pathobiology of septicemia and septic shock. J Assoc Physicians India 48:1181-1184, 2000.
4. Vincent JL: Is the current management of severe sepsis and septic shock really evidence based. PLoS Med 3:e346, 2006.
5. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36:296-327, 2008.
6. Riedemann NC, Guo RF, Ward PA: The enigma of sepsis. J Clin Invest 112: 460-467, 2003.
7. Chen CC, Lau LF: Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol 41:771-783, 2009.
8. Li HH, Li Q, Liu P, Liu Y, Li J, Wasserloos K, Chao W, You M, Oury TD, Chhinder S, et al.: WNT1-inducible signaling pathway protein 1 contributes to ventilator-induced lung injury. Am J Respir Cell Mol Biol 47:528-535, 2012.
9. Konigshoff M, Kramer M, Balsara N, Wilhelm J, Amarie OV, Jahn A, Rose F, Fink L, Seeger W, Schaefer L, et al.: WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest 119:772-787, 2009.
10. Hynes RO: Integrins: versatility modulation, and signaling in cell adhesion. Cell 69:11-25, 1992.
11. Chung A, Gao Q, Kao WJ: Macrophage matrix metalloproteinase-2/-9 gene and protein expression following adhesion to ECM-derived multifunctional matrices via integrin complexation. Biomaterials 28:285-298, 2007.
12. Moon C, Han JR, Park HJ, Hah JS, Kang JL: Synthetic RGDS peptide attenuates lipopolysaccharide-induced pulmonary inflammation by inhibiting integrin signaled MAP kinase pathways. Respir Res 10:18-32, 2009.
13. Wang B, Wan JY, Zhang L, Min S: Synthetic RGDS peptide attenuates mechanical ventilation-induced lung injury in rats. Exp Lung Res 38:204-210, 2012.
14. Wichterman KA, Baue AE, Chaudry IH: Sepsis and septic shockVa review of laboratory models and a proposal. J Surg Res 29:189-201, 1980.
15. Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA: Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 4:31-36, 2009.
16. Li H, Su X, Yan X, Wasserloos K, Chao W, Kaynar AM, Liu ZQ, Leikauf GD, Pitt BR, Zhang LM: Toll-like receptor 4-myeloid differentiation factor 88 signaling contributes to ventilator-induced lung injury in mice. Anesthesiology 113: 619-629, 2010.
17. Xu L, Bao HG, Si YN, Han L, Zhang R, Cai MM, Shen Y: Effects of adiponectin on acute lung injury in cecal ligation and puncture-induced sepsis rats. J Surg Res 183:752-759, 2013.
18. Hudson LD, Milberg JA, Anardi D, Maunder RJ: Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 151:293-301, 1995.
19. Newman JH: Sepsis and pulmonary edema. Clin Chest Med 6:371-391, 1985.
20. Tsushima K, King LS, Aggarwal NR, De Gorordo A, D-Alessio FR, Kubo K: Acute lung injury review. Intern Med 48:621-630, 2009.
21. Chen J, Raj N, Kim P, Andrejko KM, Deutschman CS: Intrahepatic nuclear factor-kappa B activity and alpha 1-acid glycoprotein transcription do not predict outcome after cecal ligation and puncture in the rat. Crit Care Med 29:589-596, 2001.
22. Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P, Lamy M: Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 215:356-362, 1992.
23. Berschneider B, Konigshoff M: WNT1 inducible signaling pathway protein 1 (Wisp1): a novel mediator linking development and disease. Int J Biochem Cell Biol 43:306-309, 2011.
24. Heise RL, Stober V, Cheluvaraju C, Hollingsworth JW, Garantziotis S: Mechanical stretch induces epithelial-mesenchymal transition in alveolar epithelia via hyaluronan activation of innate immunity. J Biol Chem 286:17435-17444, 2011.
25. Giancotti FG, Mainiero F: Integrin-mediated adhesion and signaling in tumorigenesis. Biochim Biophys Acta 1198:47-64, 1994.
26. Sheppard D, Rozzo C, Starr L, Quaranta V, Erle DJ, Pytela R: Complete amino acid sequence of a novel integrin beta subunit (beta 6) identified in epithelial cells using the polymerase chain reaction. J Biol Chem 265:11502-11507, 1990.
27. Busk M, Pytela R, Sheppard D: Characterization of the integrin alpha v beta 6 as a fibronectin-binding protein. J Biol Chem 267:5790-5796, 1992.
28. Breuss JM, Gallo J, DeLisser HM, Klimanskaya IV, Folkesson HG, Pittet JF, Nishimura SL, Aldape K, Landers DV, Carpenter W: Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci 2241-2251, 1995.
29. Hogmalm A, Sheppard D, Lappalainen U, Bry K: beta6 Integrin subunit deficiency alleviates lung injury in a mouse model of bronchopulmonary dysplasia. Am J Respir Cell Mol Biol 43:88-98, 2010.
30. Miller LA, Barnett NL, Sheppard D, Hyde DM: Expression of the beta6 integrin subunit is associated with sites of neutrophil influx in lung epithelium. J Histochem Cytochem 49:41-48, 2001.
31. Danhier F, Le Breton A, Pré at V: RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis. Mol Pharm 9:2961-2973, 2012.